Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction

Hepatology

Volumn 43, Issue 5, 2006, Pages 1092-1100

  Brandoni, Anabel ^a   Villar, Silvina R ^a   Picena, Juan C ^b   Anzai, Naohiko ^c   Endou, Hitoshi ^c   Torres, Adriana M ^a,d  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Department of Pharmacology ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; ELECTROPHORESIS; EXTRAHEPATIC BILE DUCT OBSTRUCTION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; KIDNEY CLEARANCE; KIDNEY CORTEX; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACUTE DISEASE; ANIMALS; CHOLESTASIS, EXTRAHEPATIC; KIDNEY CORTEX; MALE; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS; RATS, WISTAR;

EID: 33646567499     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21142     Document Type: Article

References (47)

1. Koopen NR, Müller M, Vonk RJ, Zimniak P, Kuipers F. Molecular mechanisms of cholestasis: causes and consequences of impaired bile formation. Biochim Biophys Acta 1998;1408:1-17.
2. Reichen J, Simon FR. Cholestasis. In: Arias MI, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. 2nd ed. New York: Raven Press, 1988;1105-1124.
3. Kramer HJ. Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems. Nephron 1997;77:1-12.
4. Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg 1989;157:256-263.
5. Fleck Ch, Bräunlich H. Renal handling of drugs and amino acids after impairment of kidney or liver function-Influences of maturity and protective treatment. Pharmacol Ther 1995;67:53-57.
6. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004;84:987-1049.
7. Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. Am J Physiol 2000;278:F853-F866.
8. Sweet DH, Bush KT, Nigam SK. The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol 2001;281:F197-F205.
9. Cha SH, Sekine T, Fukushima J-I, Kanai Y, Kobayashi Y, Goya T, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 2001;59:1277-1286.
10. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997;272:18526-18529.
11. Smeets PH, van Aubel RA, Wouterse AC, van den Heuvel JJ, Russel FG. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. J Am Soc Nephrol 2004;15:2828-2835.
12. Van Aubel R, Peters JG, Masereeuw R, Van Os CH, Russel FGM. Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classical renal organic anion p-aminohippurate. Am J Physiol 2000;279:F713-F717.
13. Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol 2002;282:G656-G662.
14. Brandoni A, Quaglia NB, Torres AM. Compensation increase in organic anion excretion in rats with acute biliary obstruction: role of the renal organic anion transporter 1. Pharmacology 2003;68:57-63.
15. Jackson E. Diureticos. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Las Bases Farmacológicas de la Terapéutica. 9th ed. Mexico: McGraw-Hill Interamericana, 1996:735-766.
16. Okusa MD, Ellison DH. Physiology and pathophysiology of diuretics. In: Seldin DW, Giebisch G, eds. The Kidney Physiology and Pathophysiology. Philadelphia: Lippincott Williams & Wilkins, 2000:2877-2922.
17. Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 2004;308:1021-1029.
18. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999;274:13675-13680.
19. Uwai Y, Saito H, Hashimoto Y, Inui KI. Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter r OAT1. J Pharmacol Exp Ther 2000;295:261-265.
20. Cerrutti JA, Quaglia NB, Brandoni A, Torres AM. Effects of gender on the pharmacokinetics of drug secreted by the renal organic anions transport systems in the rat. Pharm Res 2002;45:107-112.
21. Cerrutti JA, Quaglia NB, Torres AM. Characterization of the mechanisms involved in the gender differences in p-aminohippurate renal elimination in rats. Can J Physiol Pharmacol 2001;79:805-813.
22. Quaglia NB, Hofer CG, Torres AM. Pharmacokinetics of organic anions in rats with arterial calcinosis. Clin Exp Pharmacol Physiol 2002;29:48-52.
23. Shumaker R. PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 1986;17:331-348.
24. Motulsky H. Using nonlinear regression to fit curves. In: Motulsky H, ed. Intuitive Biostatistics. New York: Oxford University Press, 1995:227-283.
25. Bratton AC, Marshall EK Jr. Determination of p-aminohippurate. J Biol Chem 1939;128:537-542.
26. Brandoni A, Villar SR, Torres AM. Gender-related differences in the pharmacodynamics of furosemide in rats. Pharmacology 2004;70:107-112.
27. Quaglia NB, Brandoni A, Ferri A, Torres AM. Early manifestation of nephropathy in rats with arterial calcinosis. Renal Fail 2003;25:355-366.
28. Quaglia NB, Brandoni A, Villar SR, Torres AM. Haemodynamic and tubular renal dysfunction in rats with sustained arterial calcinosis. Clin Exp Pharmacol Physiol 2004;31:231-236.
29. Roe HH. A photometric method for determination of inulin in plasma and urine. J Biol Chem 1949;178:839-844.
30. Jensen RE, Berndt WO. Epinephrine and norephinephrine enhance p-aminohippurate transport into basolateral membrane vesicles. J Pharmacol Exp Ther 1988;244:543-549.
31. Cerrutti JA, Brandoni A, Quaglia NB, Torres AM. Sex differences in p-aminohippuric acid transport in rat kidney: role of membrane fluidity and expression of OAT1. Mol Cell Biochem 2002;233:175-179.
32. Schoner W, Von Ilberg C, Kramer R, Seubert W. On the mechanism of Na+ and K+ stimulation hydrolysis of adenosine triphosphate. Eur J Biochem 1967;1:334-343.
33. Widnell CB. Purification of rat liver 5′nucleotidase as a complex with sphingomyelin. Methods Enzymol 1974;32:368-374.
34. Torres AM, MacLaughlin M, Quaglia NB, Stremmel W. Role of BSP/bilirubin binding protein on p-aminohippurate transport in rat kidney. Mol Cell Biochem 2003;248:149-156.
35. Villar SR, Brandoni A, Anzai N, Endou H, Torres AM. Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int 2005,68:2704-2713.
36. Sedmak JJ, Grossberg SE. A rapid, sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal Biochem 1977;79:544-552.
37. Villar SR, Brandoni A, Quaglia NB, Torres AM. Renal elimination of organic anions in rats with bilateral ureteral obstruction. Biochim Biophys Acta 2004;1688:204-209.
38. Torres AM, MacLaughlin M, Muller A, Brandoni A, Anzai N, Endou H. Altered renal elimination of organic anions in rats with chronic renal failure. Biochim Biophys Acta 2005;1740:29-37.
39. Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, et al. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 1999;10:464-471.
40. Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol 2001;280:G1209-G1216.
41. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 2002;13:848-857.
42. Wójcicki M, Drozdzik M, Sulikowski T, Wójcicki J, Gawronska-Szklarz B, Zielinski S, et al. Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstruction. Eur J Pharm Sci 2000;11:215-222.
43. Sitprija V, Kashemsant U, Sriratanban A, Arthachinta S, Poshyachinda V. Renal function in obstructive jaundice in man:cholangiocarcinoma model. Kidney Int 1990;38:948-9555.
44. Miyazawa Y, Sato T, Kobayashi K, Akahoti F, Suzuki T, Miyashita H. Influence of induced cholestasis on pharmacokinetics of digoxin and digitoxin in dogs. Am J Vet Res 1990;51:605-610.
45. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987;39:1-47.
46. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, et al. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol 2004;287:F124-F138.
47. Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, Infantolino D. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol 1999;26:358-363.